e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Inflammation and obesity: implications for OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chronic intermittent hypoxia induces features of non alcoholic fatty liver disease (NAFLD) and modifies adipose tissue characteristics in lean mice
J. Aron-Wisnewsky, E. Gras, A. Thomas, D. Godin-Ribuot, K. Clement, J. L. Pepin (Paris, La Tronche, Grenoble Cedex 09, France)
Source:
International Congress 2014 – Inflammation and obesity: implications for OSA
Session:
Inflammation and obesity: implications for OSA
Session type:
Oral Presentation
Number:
4445
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Aron-Wisnewsky, E. Gras, A. Thomas, D. Godin-Ribuot, K. Clement, J. L. Pepin (Paris, La Tronche, Grenoble Cedex 09, France). Chronic intermittent hypoxia induces features of non alcoholic fatty liver disease (NAFLD) and modifies adipose tissue characteristics in lean mice. Eur Respir J 2014; 44: Suppl. 58, 4445
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
PERIPHERAL ARTERIAL TONOMETRY AND INTIMA MEDIA THICKNESS IN OBSTRUCTIVE SLEEP APNEA.
Related content which might interest you:
The effect of chronic intermittent hypoxia on hepatic injury and mechanism in lean mice and mice with diet-induced obesity
Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing
Year: 2014
Chronic intermittent hypoxia induces liver injury in mice with diet induced obesity via TLR4/MyD88/MAPK/NF-kB signaling pathways
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016
Significant associations between obstructive sleep apnea and fat accumulation in the liver in male subjects without visceral obesity
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
The influence of obstructive sleep apneao–induced intermittant Hypoxia on Non Alcoholic Fatty liver.
Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Year: 2017
Brain oxidative stress induced by recurrent obstructive apneas: Old versus young rats
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013
Impacts of long-term CPAP therapy on fatty liver in male OSA patients with abdominal obesity
Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Year: 2014
CPAP treatment: effects on plasma lipids and liver function
Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options
Year: 2009
In sleep apnea patients nonalcoholic fatty liver disease (NAFLD) is associated with the severity of intermittent hypoxia and more severe endothelial dysfunction
Source: Annual Congress 2012 - Sleep disorders in internal medicine
Year: 2012
Does sleep loss play a role in adipose tissue dysfunction?
Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options
Year: 2009
Inflammation in obese adipose tissue
Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options
Year: 2009
Hypertension induced by chronic intermittent hypoxia: Effects of carvedilol in a rat model
Source: International Congress 2015 – A bout de souffle: hypoxia and sleep-disordered breathing
Year: 2015
Chronic intermittent hypoxia reduces progressive sperm motility in a mouse model of obstructive sleep apnea
Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing
Year: 2013
Effects of obstructive sleep apnoea on systemic inflammation and adipose tissue expression of CD40, MKK4 and JNK
Source: International Congress 2014 – Inflammation and obesity: implications for OSA
Year: 2014
Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in male and female patients with OSAS
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014
Obesity and chronic intermittent hypoxia are independent risk factors for clinical decompensation in patients with cirrhosis and OSAS
Source: International Congress 2014 – Inflammation and obesity: implications for OSA
Year: 2014
Effects of normoxic recovery on intermittent hypoxia-induced changes of microbiome in a mouse model of OSA
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016
Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease
Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea
Year: 2011
Association between obstructive sleep apnea and the severity of non-alcoholic fatty liver disease.
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019
Visceral adipose tissue as a target for therapeutic intervention: an update
Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept